Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John B Lynch

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
The Medical Clinics of North America|July 2, 2013
Multidrug-resistant TuberculosisJohn B Lynch
Healthcare Financial Management : Journal of the Healthcare Financial Management Association|May 18, 2016
Promoting value through antimicrobial stewardshipJohn B Lynch
JAMA Network Open|August 14, 2024
Vaccine Mandates for Health Care Workers-An Effective Policy Tool for Past and Future PandemicsJohn B Lynch
Drug Design, Development and Therapy|February 14, 2015
Profile of delamanid for the treatment of multidrug-resistant tuberculosisJohn D Szumowski, John B Lynch
The New England Journal of Medicine|April 25, 2020
Mild or Moderate Covid-19Rajesh T Gandhi, John B Lynch, Carlos Del Rio
Journal of Intensive Care Medicine|May 11, 2017
Hospital Length of Stay Among Patients Receiving Intermittent Versus Prolonged Piperacillin/Tazobactam Infusion in the Intensive Care UnitsJeannie D Chan, Timothy H Dellit, John B Lynch
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 3, 2021
Follow-up blood cultures in E. coli and Klebsiella spp. bacteremia-opportunities for diagnostic and antimicrobial stewardshipJeannie D Chan, Ashley Ta, John B Lynch, et al.
Open Forum Infectious Diseases|July 16, 2016
Infectious Diseases Physician Compensation: An Improved PerspectiveJethro Trees Ritter, John B Lynch, Ann T MacIntyre, et al.
Open Forum Infectious Diseases|December 5, 2019
Risk Factors for BI/NAP1/027 <i>Clostridioides difficile</i> Infections and Clinical Outcomes Compared With Non-NAP1 StrainsNandita S Mani, John B Lynch, Ferric C Fang, et al.
Diagnostic Microbiology and Infectious Disease|September 20, 2011
Relationships between vancomycin minimum inhibitory concentration, dosing strategies, and outcomes in methicillin-resistant Staphylococcus aureus bacteremiaEvan C Clemens, Jeannie D Chan, John B Lynch, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
The Medical Clinics of North America|July 2, 2013
Multidrug-resistant TuberculosisJohn B Lynch
Healthcare Financial Management : Journal of the Healthcare Financial Management Association|May 18, 2016
Promoting value through antimicrobial stewardshipJohn B Lynch
JAMA Network Open|August 14, 2024
Vaccine Mandates for Health Care Workers-An Effective Policy Tool for Past and Future PandemicsJohn B Lynch
Drug Design, Development and Therapy|February 14, 2015
Profile of delamanid for the treatment of multidrug-resistant tuberculosisJohn D Szumowski, John B Lynch
The New England Journal of Medicine|April 25, 2020
Mild or Moderate Covid-19Rajesh T Gandhi, John B Lynch, Carlos Del Rio
Journal of Intensive Care Medicine|May 11, 2017
Hospital Length of Stay Among Patients Receiving Intermittent Versus Prolonged Piperacillin/Tazobactam Infusion in the Intensive Care UnitsJeannie D Chan, Timothy H Dellit, John B Lynch
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 3, 2021
Follow-up blood cultures in E. coli and Klebsiella spp. bacteremia-opportunities for diagnostic and antimicrobial stewardshipJeannie D Chan, Ashley Ta, John B Lynch, et al.
Open Forum Infectious Diseases|July 16, 2016
Infectious Diseases Physician Compensation: An Improved PerspectiveJethro Trees Ritter, John B Lynch, Ann T MacIntyre, et al.
Open Forum Infectious Diseases|December 5, 2019
Risk Factors for BI/NAP1/027 <i>Clostridioides difficile</i> Infections and Clinical Outcomes Compared With Non-NAP1 StrainsNandita S Mani, John B Lynch, Ferric C Fang, et al.
Diagnostic Microbiology and Infectious Disease|September 20, 2011
Relationships between vancomycin minimum inhibitory concentration, dosing strategies, and outcomes in methicillin-resistant Staphylococcus aureus bacteremiaEvan C Clemens, Jeannie D Chan, John B Lynch, et al.
Pageof 7